Gene · 9252
Papers1,701
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,701
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitogen-Activated Protein Kinases (MAPKs) and Enteric Bacterial Pathogens: A Complex Interplay. | Int J Mol Sci | 2023 | 37569283 | PubTator, text mining | PubMed |
| Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond. | Front Immunol | 2023 | 37539051 | PubTator, text mining | PubMed |
| In silico identification of potential miRNAs -mRNA inflammatory networks implicated in the pathogenesis of COVID-19. | Hum Gene (Amst) | 2023 | 37520333 | PubTator, text mining | PubMed |
| Identification of hub genes and therapeutic drugs in osteonecrosis of the femoral head through integrated bioinformatics analysis and literature mining. | Sci Rep | 2023 | 37488209 | PubTator, text mining | PubMed |
| Sequence variants contributing to dysregulated inflammatory responses across keratoconic cone surface in adolescent patients with keratoconus. | Front Immunol | 2023 | 37483635 | PubTator, text mining | PubMed |
| Identified Isosteric Replacements of Ligands' Glycosyl Domain by Data Mining. | ACS Omega | 2023 | 37483233 | PubTator, text mining | PubMed |
| Experimental Insights into the Interplay between Histone Modifiers and p53 in Regulating Gene Expression. | Int J Mol Sci | 2023 | 37446210 | PubTator, text mining | PubMed |
| Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2023 | 37445986 | PubTator, text mining | PubMed |
| Exploring the Therapeutic Potential of trans-Chalcone: Modulation of MicroRNAs Linked to Breast Cancer Progression in MCF-7 Cells. | Int J Mol Sci | 2023 | 37445965 | PubTator, text mining | PubMed |
| Accuracy of a Smartphone-Based Artificial Intelligence Application for Classification of Melanomas, Melanocytic Nevi, and Seborrheic Keratoses. | Diagnostics (Basel) | 2023 | 37443533 | PubTator, text mining | PubMed |
| PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation. | Biol Direct | 2023 | 37434235 | PubTator, text mining | PubMed |
| MSK1 is required for the beneficial synaptic and cognitive effects of enriched experience across the lifespan. | Aging (Albany NY) | 2023 | 37432063 | PubTator, text mining | PubMed |
| A2AR-mediated lymphangiogenesis via VEGFR2 signaling prevents salt-sensitive hypertension. | Eur Heart J | 2023 | 37377160 | PubTator, text mining | PubMed |
| Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs. | Cells | 2023 | 37371063 | PubTator, text mining | PubMed |
| HIV and Drug Use: A Tale of Synergy in Pulmonary Vascular Disease Development. | Compr Physiol | 2023 | 37358518 | PubTator, text mining | PubMed |
| SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication. | mBio | 2023 | 37345956 | PubTator, text mining | PubMed |
| Awakening of Dormant Breast Cancer Cells in the Bone Marrow. | Cancers (Basel) | 2023 | 37296983 | PubTator, text mining | PubMed |
| Epigenetic markers and therapeutic targets for metastasis. | Cancer Metastasis Rev | 2023 | 37286865 | PubTator, text mining | PubMed |
| Phenolic Acids-Mediated Regulation of Molecular Targets in Ovarian Cancer: Current Understanding and Future Perspectives. | Pharmaceuticals (Basel) | 2023 | 37259418 | PubTator, text mining | PubMed |
| AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK. | PLoS Comput Biol | 2023 | 37235579 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9252/papers?page=5